Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Treasury Shares: 2018-2024

Historic Treasury Shares for Revolution Medicines (RVMD) over the last 7 years, with Dec 2024 value amounting to $2.9 million.

  • Revolution Medicines' Treasury Shares rose 29.49% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 29.49%. This contributed to the annual value of $2.9 million for FY2024, which is 31.87% up from last year.
  • Per Revolution Medicines' latest filing, its Treasury Shares stood at $2.9 million for FY2024, which was up 31.87% from $2.2 million recorded in FY2023.
  • In the past 5 years, Revolution Medicines' Treasury Shares registered a high of $2.9 million during FY2024, and its lowest value of $272 during FY2022.
  • In the last 3 years, Revolution Medicines' Treasury Shares had a median value of $2.2 million in 2023 and averaged $1.7 million.
  • In the last 5 years, Revolution Medicines' Treasury Shares tumbled by 95.30% in 2022 and then skyrocketed by 794,483.46% in 2023.
  • Yearly analysis of 5 years shows Revolution Medicines' Treasury Shares stood at $18,158 in 2020, then crashed by 68.10% to $5,793 in 2021, then plummeted by 95.30% to $272 in 2022, then spiked by 794,483.46% to $2.2 million in 2023, then skyrocketed by 31.87% to $2.9 million in 2024.